176 related articles for article (PubMed ID: 36216174)
1. Chitosan on the surface of nanoparticles for enhanced drug delivery: A comprehensive review.
Elkomy MH; Ali AA; Eid HM
J Control Release; 2022 Nov; 351():923-940. PubMed ID: 36216174
[TBL] [Abstract][Full Text] [Related]
2. A close collaboration of chitosan with lipid colloidal carriers for drug delivery applications.
Bugnicourt L; Ladavière C
J Control Release; 2017 Jun; 256():121-140. PubMed ID: 28414148
[TBL] [Abstract][Full Text] [Related]
3. Solid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake.
Luo Y; Teng Z; Li Y; Wang Q
Carbohydr Polym; 2015 May; 122():221-9. PubMed ID: 25817662
[TBL] [Abstract][Full Text] [Related]
4. Preparation, intestinal segment stability, and mucoadhesion properties of novel thymopentin-loaded chitosan derivatives coated with poly (n-butyl) cyanoacrylate nanoparticles.
Xu Y; Lu S; Liu Q; Hong Y; Xu B; Ping Q; Jin X; Shen Y; Webster TJ; Rao Y
Int J Nanomedicine; 2019; 14():1659-1668. PubMed ID: 30880971
[TBL] [Abstract][Full Text] [Related]
5. Chitosan Nanoparticles as Oral Drug Carriers.
Guadarrama-Escobar OR; Serrano-Castañeda P; Anguiano-Almazán E; Vázquez-Durán A; Peña-Juárez MC; Vera-Graziano R; Morales-Florido MI; Rodriguez-Perez B; Rodriguez-Cruz IM; Miranda-Calderón JE; Escobar-Chávez JJ
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901719
[TBL] [Abstract][Full Text] [Related]
6. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
[TBL] [Abstract][Full Text] [Related]
7. Facile fabrication of poly(acrylic acid) coated chitosan nanoparticles with improved stability in biological environments.
Wu Y; Wu J; Cao J; Zhang Y; Xu Z; Qin X; Wang W; Yuan Z
Eur J Pharm Biopharm; 2017 Mar; 112():148-154. PubMed ID: 27890571
[TBL] [Abstract][Full Text] [Related]
8. In Vitro Comparative Study of Solid Lipid and PLGA Nanoparticles Designed to Facilitate Nose-to-Brain Delivery of Insulin.
Akel H; Csóka I; Ambrus R; Bocsik A; Gróf I; Mészáros M; Szecskó A; Kozma G; Veszelka S; Deli MA; Kónya Z; Katona G
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948054
[TBL] [Abstract][Full Text] [Related]
9. In vitro-in vivo evaluation of chitosan-PLGA nanoparticles for potentiated gastric retention and anti-ulcer activity of diosmin.
Abd El Hady WE; Mohamed EA; Soliman OAE; El-Sabbagh HM
Int J Nanomedicine; 2019; 14():7191-7213. PubMed ID: 31564873
[TBL] [Abstract][Full Text] [Related]
10. Novel chitosan-functionalized spherical nanosilica matrix as an oral sustained drug delivery system for poorly water-soluble drug carvedilol.
Sun L; Wang Y; Jiang T; Zheng X; Zhang J; Sun J; Sun C; Wang S
ACS Appl Mater Interfaces; 2013 Jan; 5(1):103-13. PubMed ID: 23237208
[TBL] [Abstract][Full Text] [Related]
11. Unveiling the potential of chitosan-coated lipid nanoparticles in drug delivery for management of critical illness: a review.
Das U; Kapoor DU; Singh S; Prajapati BG
Z Naturforsch C J Biosci; 2024 May; 79(5-6):107-124. PubMed ID: 38721838
[TBL] [Abstract][Full Text] [Related]
12. Improved oral delivery of resveratrol from N-trimethyl chitosan-g-palmitic acid surface-modified solid lipid nanoparticles.
Ramalingam P; Ko YT
Colloids Surf B Biointerfaces; 2016 Mar; 139():52-61. PubMed ID: 26700233
[TBL] [Abstract][Full Text] [Related]
13. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C
Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340
[TBL] [Abstract][Full Text] [Related]
14. Development, Optimization, and In Vitro/In Vivo Characterization of Enhanced Lipid Nanoparticles for Ocular Delivery of Ofloxacin: the Influence of Pegylation and Chitosan Coating.
Eid HM; Elkomy MH; El Menshawe SF; Salem HF
AAPS PharmSciTech; 2019 May; 20(5):183. PubMed ID: 31054011
[TBL] [Abstract][Full Text] [Related]
15. Current applications of solid lipid nanoparticles and nanostructured lipid carriers as vehicles in oral delivery systems for antioxidant nutraceuticals: A review.
Gunawan M; Boonkanokwong V
Colloids Surf B Biointerfaces; 2024 Jan; 233():113608. PubMed ID: 37925866
[TBL] [Abstract][Full Text] [Related]
16. Development and in vitro characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil.
Mohammed M; Mansell H; Shoker A; Wasan KM; Wasan EK
Drug Dev Ind Pharm; 2019 Jan; 45(1):76-87. PubMed ID: 30169982
[TBL] [Abstract][Full Text] [Related]
17. Positively Charged Nanostructured Lipid Carriers and Their Effect on the Dissolution of Poorly Soluble Drugs.
Choi KO; Choe J; Suh S; Ko S
Molecules; 2016 May; 21(5):. PubMed ID: 27213324
[TBL] [Abstract][Full Text] [Related]
18. Enhancing Stability and Mucoadhesive Properties of Chitosan Nanoparticles by Surface Modification with Sodium Alginate and Polyethylene Glycol for Potential Oral Mucosa Vaccine Delivery.
Amin MK; Boateng JS
Mar Drugs; 2022 Feb; 20(3):. PubMed ID: 35323455
[No Abstract] [Full Text] [Related]
19. Low molecular weight chitosan-coated polymeric nanoparticles for sustained and pH-sensitive delivery of paclitaxel.
Abouelmagd SA; Ku YJ; Yeo Y
J Drug Target; 2015; 23(7-8):725-35. PubMed ID: 26453168
[TBL] [Abstract][Full Text] [Related]
20. Advances and Potential Applications of Chitosan Nanoparticles as a Delivery Carrier for the Mucosal Immunity of Vaccine.
Li D; Fu D; Kang H; Rong G; Jin Z; Wang X; Zhao K
Curr Drug Deliv; 2017; 14(1):27-35. PubMed ID: 27494157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
